During the past decade, University Hospitals Parma Medical Center conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 36 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 24 clinical trials were completed. i.e. 109.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals Parma Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "NRG Oncology" with 15 trials sponsored, "Radiation Therapy Oncology Group" with 10 trials sponsored and "Alliance for Clinical Trials in Oncology" with 10 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals Parma Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Radiation Therapy Oncology Group" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals Parma Medical Center" are "Breast Cancer" (9 trials), "Lung Cancer" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials), "Invasive Breast Carcinoma" (5 trials) and "Metastatic Malignant Neoplasm in the Brain" (4 trials). Many other conditions were trialed in "University Hospitals Parma Medical Center" in a lesser frequency.

Most popular intervention types in "University Hospitals Parma Medical Center" are "Drug" (82 trials), "Other" (46 trials), "Radiation" (37 trials), "Biological" (31 trials) and "Procedure" (20 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Quality-of-Life Assessment" (16 trials), "Carboplatin" (11 trials), "Cisplatin" (11 trials) and "Computed Tomography" (11 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals Parma Medical Center" are 76 trials for "All" genders, 13 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospitals Parma Medical Center". undefined are not yet recruiting, 24 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in University Hospitals Parma Medical Center, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals Parma Medical Center, 1 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".